Jose Jimenez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Quality and safety of research biopsies in oncology clinical trials.

Quality and safety of research biopsies in oncology clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2026

Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study.

Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study.

Journal: ESMO open

Published: January 30, 2026

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 27, 2026

Evolving landscape of targeted therapies in early phase clinical trials.

Evolving landscape of targeted therapies in early phase clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 04, 2026

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.

Journal: Annals of the rheumatic diseases

Published: July 13, 2025

Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 23, 2025

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Journal: Immuno-oncology technology

Published: February 06, 2025

A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.

A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.

Journal: Med (New York, N.Y.)

Published: January 22, 2023

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.

Journal: ESMO open

Published: December 14, 2022

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.

Journal: International journal of molecular sciences

Published: October 19, 2022

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

Journal: Journal for immunotherapy of cancer

Published: February 24, 2022

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.

Journal: Breast (Edinburgh, Scotland)

Published: September 21, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026